Fig. 3 | Scientific Reports

Fig. 3

From: CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients

Fig. 3

Expression of CD71 on neutrophils correlates with the activation of platelets in PDAC patients. CRP values in the plasma of clinical control (n = 21) and PDAC patients (n = 70). CRP values in plasma correlated to the expression of CD71 on neutrophils in PDAC patients (A); leukocyte count in the blood of clinical control (n = 21) and PDAC patients (n = 70). Leukocyte count in blood correlated to the expression of CD71 on neutrophils in PDAC patients (B); platelet count in the blood of clinical control (n = 21) and PDAC patients (n = 70). Platelet count in blood correlated to the expression of CD71 on neutrophils in PDAC patients (C); Expression of the activationmarker CD42a on platelets in clinical control (n = 14) and PDAC patients (n = 45) and the correlation of CD42a on platelets with CD71 on neutrophils in PDAC patients (D); **p < 0.01.

Back to article page